Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Sees Significant Increase in Short Interest

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 5,100 shares, a growth of 363.6% from the January 15th total of 1,100 shares. Based on an average daily trading volume, of 13,000 shares, the short-interest ratio is presently 0.4 days.

Algernon Pharmaceuticals Price Performance

Shares of OTCMKTS:AGNPF opened at $0.08 on Thursday. The business’s 50 day simple moving average is $0.05 and its 200 day simple moving average is $0.06. Algernon Pharmaceuticals has a 1 year low of $0.04 and a 1 year high of $0.12.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.